Premier has published an update summarizing the most recent changes to President Trump’s tariffs and what they mean for healthcare.
Report summary:
- The enactment of the 10% tariffs on imported goods was April 5th.
- Reciprocal tariffs are to be halted through early July “apart from China, where tariff rates are currently up to 245 percent.”
- Presently, there is no known enteral feeding syringe “manufacturing outside of China and are currently subject to a 245 percent tariff.”
- “Tariffs on imported goods could affect the prices and availability of the approximately 75 percent of U.S.-marketed medical devices that are manufactured out of the country, and more specifically the 69 percent of U.S.-marketed devices that are manufactured exclusively outside of the U.S.”
- Tariffs are now being discussed for pharmaceutical imports.
Additionally, Premier listed suggestions for healthcare leaders to ease stress and plan ahead.
